- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | HeartSciences Inc.: HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results | 200 | GlobeNewswire (Europe) | Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch... ► Artikel lesen | |
| 23.07. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.07. | HeartSciences Inc.: HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K | 1 | GlobeNewswire (USA) | ||
| 23.07. | HeartSciences Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 10.07. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.06. | Fortitude And HeartSciences Announce Business Combination | 1 | pulse2.com | ||
| 23.06. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | Fortitude Mining to merge with HeartSciences in all-stock deal | 2 | Investing.com | ||
| HEARTSCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.06. | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | 225 | Business Wire | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| 11.06. | HeartSciences Inc.: European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents | 250 | GlobeNewswire (Europe) | Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 02.06. | HeartSciences Inc.: HeartSciences Launches MyoVista Insights Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm | 1 | GlobeNewswire (USA) | ||
| 19.05. | HeartSciences signs North Shore Health for MyoVista platform | 1 | Investing.com | ||
| 19.05. | HeartSciences Inc.: HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network | 1 | GlobeNewswire (USA) | ||
| 06.05. | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.05. | HeartSciences Inc.: HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights | 268 | GlobeNewswire (Europe) | Southlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 14.04. | HeartSciences Inc.: HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting | 1 | GlobeNewswire (USA) | ||
| 03.04. | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
| 25.03. | HeartSciences Inc.: HeartSciences' MyoVista Insights Receives Epic Toolbox Designation for ECG Management System Category | 1 | GlobeNewswire (USA) | ||
| 17.03. | Heart Test Laboratories GAAP EPS of -$0.63 beats by $0.19 | 1 | Seeking Alpha | ||
| 16.03. | HeartSciences Inc.: HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | 357 | GlobeNewswire (Europe) | Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,415 | +1,97 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,220 | +2,85 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,330 | -3,62 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 44,200 | -2,64 % | Inspire Medical August 2026 slides: $10B market opportunity meets reimbursement reset | ||
| INSPIREMD | 0,580 | -1,69 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,310 | +0,42 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,866 | -4,63 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,700 | -2,56 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| INTELLIGENT BIO SOLUTIONS | 1,820 | +1,11 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 2,915 | 0,00 % | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 4,500 | -5,26 % | Lexaria Bioscience Corp.: Lexaria Announces Effective Date for Reverse Stock Split | KELOWNA, BC / ACCESS Newswire / July 30, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it intends to effect... ► Artikel lesen | |
| GLUCOTRACK | 0,415 | 0,00 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| LENSAR | 5,430 | +0,93 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 1,990 | 0,00 % | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| HEARTBEAM | 0,493 | 0,00 % | HeartBeam receives patent for multi-modal cardiac sensing device |
HEARTSCIENCES INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,130 Euro und damit -0,47 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTSCIENCES INC finden Sie auf Wallstreet Online.